Additional file 3.
JNK inhibitor SP-600125 reduces TRAIL promoter activity induced by IFN-α in caPKC-δ-overexpressing Daudi B lymphoma cells. The caPKC-δ-overexpressing Daudi B lymphoma cells were pretreated with SP-600125 for 1 h, stimulated with 1,000 U/ml IFN-α for 24 h, and then assayed for luciferase activity. *Significantly different (p < 0.05) from IFN-α without JNK inhibitor.
Format: PNG Size: 157KB Download file
Yanase et al. BMC Cell Biology 2012 13:7 doi:10.1186/1471-2121-13-7